Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Anticipated ShortageTier 3 — Critical

BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP

FORMATIVE PHARMA INC.

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP in Canada?

A shortage of BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP 7.5MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated September 21, 2026), but it has not started yet.

Why is BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP not available?

The reason the manufacturer reported: Requirements related to complying with good manufacturing practices.

When will BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP be available again?

No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.

Can I still get this?Check with your pharmacist — only products with a different form or route found
StatusAnticipated Shortage
Same-ingredient products on file3 products · 0 same form & route
Affected strength7.5MG
Report last updated2026-09-21
Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

BUPIVACAINE HYDROCHLORIDE INJECTION, USP

BAXTER CORPORATION

7.5MG · DIN 02488930

Same strengthSame dosage formDifferent routeNo current shortage

SENSORCAINE

ASPEN PHARMACARE CANADA INC.

2.5MG · DIN 01976141

Different strengthSame dosage formDifferent routeNo current shortage

BUPIVACAINE INJECTION BP

STERIMAX INC

2.5MG · DIN 02443686

Different strengthSame dosage formDifferent routeNo current shortage

What this means

Does this mean my pharmacy is already out of stock?

No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.

What should I do?

Health Canada classes this as a Tier 3 shortage, its highest-impact category. If you rely on this medication, ask your pharmacist or care team now, before the shortage starts, what the plan is if supply runs short.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02536714

Strength

7.5MG

Dosage Form

SOLUTION

Route

INTRASPINAL

Active Ingredient

BUPIVACAINE HYDROCHLORIDE

See all BUPIVACAINE HYDROCHLORIDE products →

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History